- Issuer ticker
-
ALNY
- Reported as of
-
09 Nov 2026
- Net transaction value
-
+$299,526
Source evidence
Original filing metadata and source links for verification.
4 source fields
- SEC form
-
4
- Accepted by SEC
-
12 Nov 2026, 16:01:56 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Brett Budzinski, attorney-in-fact for Amy W. Schulman
Filing notes and source
Key filing fact
Amy W. Schulman filed Form 4 for ALNYLAM PHARMACEUTICALS, INC. (ALNY) on 12 Nov 2026.
Key facts
- This page summarizes Amy W. Schulman's Form 4 filing for ALNYLAM PHARMACEUTICALS, INC. (ALNY).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 12 Nov 2026, 16:01.
Change
- Previous filing in this sequence was filed on 22 May 2026.
- Current net transaction value: +$299,526.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001438226
Primary reporting owner
SCHULMAN AMY W
- Relationship
-
Director
- Address
- 675 WEST KENDALL STREET, CAMBRIDGE
- Signature
- /s/ Brett Budzinski, attorney-in-fact for Amy W. Schulman
- Signature date
- 12 Nov 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ALNY
transaction
Common Stock
Purchase
- Transaction value
- $299,526
- Shares
- +1,910
- Change %
- +7.9%
- Price
-
$156.82
- Shares after
- 25,959
- Date
- 09 Nov 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.